Woloshin, P I; Walton, K M; Rehfuss, R P et al. (1992) 3',5'-cyclic adenosine monophosphate-regulated enhancer binding (CREB) activity is required for normal growth and differentiated phenotype in the FRTL5 thyroid follicular cell line. Mol Endocrinol 6:1725-33
|
Walton, K M; Rehfuss, R P; Chrivia, J C et al. (1992) A dominant repressor of cyclic adenosine 3',5'-monophosphate (cAMP)-regulated enhancer-binding protein activity inhibits the cAMP-mediated induction of the somatostatin promoter in vivo. Mol Endocrinol 6:647-55
|
Rehfuss, R P; Walton, K M; Loriaux, M M et al. (1991) The cAMP-regulated enhancer-binding protein ATF-1 activates transcription in response to cAMP-dependent protein kinase A. J Biol Chem 266:18431-4
|
Fink, J S; Verhave, M; Walton, K et al. (1991) Cyclic AMP- and phorbol ester-induced transcriptional activation are mediated by the same enhancer element in the human vasoactive intestinal peptide gene. J Biol Chem 266:3882-7
|
Tischler, A S; Dayal, Y; Balogh, K et al. (1987) The distribution of immunoreactive chromogranins, S-100 protein, and vasoactive intestinal peptide in compound tumors of the adrenal medulla. Hum Pathol 18:909-17
|
Goodman, R H; Leiter, A; Low, M J et al. (1987) Biosynthesis of pancreatic islet hormones. Hepatology 7:36S-41S
|
Tsukada, T; Fink, J S; Mandel, G et al. (1987) Identification of a region in the human vasoactive intestinal polypeptide gene responsible for regulation by cyclic AMP. J Biol Chem 262:8743-7
|
Lechan, R M; Wu, P; Jackson, I M et al. (1986) Thyrotropin-releasing hormone precursor: characterization in rat brain. Science 231:159-61
|
Tsukada, T; Horovitch, S J; Montminy, M R et al. (1985) Structure of the human vasoactive intestinal polypeptide gene. DNA 4:293-300
|
Leiter, A B; Montminy, M R; Jamieson, E et al. (1985) Exons of the human pancreatic polypeptide gene define functional domains of the precursor. J Biol Chem 260:13013-7
|
Showing the most recent 10 out of 11 publications